IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 97.99 USD -1.02%
Market Cap: $1.2B

Wall Street
Price Targets

IRMD Price Targets Summary
IRadimed Corp

Wall Street analysts forecast IRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRMD is 100.98 USD with a low forecast of 98.98 USD and a high forecast of 105 USD.

Lowest
Price Target
98.98 USD
1% Upside
Average
Price Target
100.98 USD
3% Upside
Highest
Price Target
105 USD
7% Upside
IRadimed Corp Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
269% Upside
CAR
Avis Budget Group Inc
26% Upside
SK
Sigdo Koppers SA
-7% Downside

Revenue
Forecast

18% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 11 years the compound annual growth rate for IRadimed Corp's revenue is 18%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

21% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
21% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 11 years the compound annual growth rate for IRadimed Corp's operating income is 21%. The projected CAGR for the next 3 years is 14%.

Net Income
Forecast

23% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
23% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

For the last 11 years the compound annual growth rate for IRadimed Corp's net income is 23%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IRMD's stock price target?
Price Target
100.98 USD

According to Wall Street analysts, the average 1-year price target for IRMD is 100.98 USD with a low forecast of 98.98 USD and a high forecast of 105 USD.

What is IRadimed Corp's Revenue forecast?
Projected CAGR
10%

For the last 11 years the compound annual growth rate for IRadimed Corp's revenue is 18%. The projected CAGR for the next 3 years is 10%.

What is IRadimed Corp's Operating Income forecast?
Projected CAGR
14%

For the last 11 years the compound annual growth rate for IRadimed Corp's operating income is 21%. The projected CAGR for the next 3 years is 14%.

What is IRadimed Corp's Net Income forecast?
Projected CAGR
12%

For the last 11 years the compound annual growth rate for IRadimed Corp's net income is 23%. The projected CAGR for the next 3 years is 12%.

Back to Top